10.10.2013 Views

NCRIS – Recombinant Protein Production Facility (RPPF) - CSIRO

NCRIS – Recombinant Protein Production Facility (RPPF) - CSIRO

NCRIS – Recombinant Protein Production Facility (RPPF) - CSIRO

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

GEA Niro Soavi homogeniser for<br />

large-scale cell lysis<br />

<strong>NCRIS</strong><br />

<strong>NCRIS</strong> is part of the Australian<br />

Government’s ‘Backing Australia’s<br />

Ability’ initiative which provides<br />

substantial funds to generate ideas,<br />

accelerate commercialisation, encourage<br />

collaboration, develop and retain skills.<br />

This <strong>NCRIS</strong> component includes nodes<br />

in the Australian Capital Territory, New<br />

South Wales, Queensland, South Australia<br />

the Victoria.<br />

Collaboration and funding<br />

The Australian Government, State<br />

Government of Victoria, <strong>CSIRO</strong> and<br />

Monash University have invested in this<br />

Victorian node to help enhance Australia’s<br />

capacity to produce recombinant proteins<br />

in pre-commercial quantities.<br />

The Victorian node is housed in a newly<br />

refurbished, dedicated laboratory at<br />

Monash University’s Centre for Green<br />

Chemistry for protein purification and<br />

purpose built pilot-scale fermentation<br />

laboratories at <strong>CSIRO</strong> Materials Science<br />

and Engineering, immediately adjacent<br />

to Monash University and the Australian<br />

Synchrotron.<br />

For production of recombinant proteins<br />

through the <strong>NCRIS</strong> program, researchers<br />

and biotechnology companies can have<br />

easy access to:<br />

• <strong>CSIRO</strong>’s fermentation production<br />

facility<br />

• Monash University’s purification facility<br />

• licensed contract manufacturing<br />

organisations (CMOs) to produce<br />

recombinant proteins under cGMP<br />

conditions for clinical trials.<br />

For further information:<br />

Contact Science:<br />

Dr George Lovrecz<br />

Head of Fermentation Group<br />

<strong>CSIRO</strong><br />

Phone: (03) 9662 7348<br />

Email: george.lovrecz@csiro.au<br />

Dr Geoff Dumsday<br />

Research Group Leader <strong>–</strong> Biotransformation<br />

<strong>CSIRO</strong><br />

Phone: (03) 9545 2344<br />

Email: geoff.dumsday@csiro.au<br />

Contact Business:<br />

Dr Kirsty Reed<br />

Business Development Manager<br />

<strong>CSIRO</strong><br />

Phone: (03) 9545 2484<br />

Email: kirsty.reed@csiro.au<br />

Web:<br />

www.csiro.au/places/<strong>Recombinant</strong>-<br />

<strong>Protein</strong>-<strong>Facility</strong>.html

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!